InvestorBrandNetwork (IBN) Content Platform

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTC: PLTXF), the digital face of the plant-based community operating a one-stop shop for plant-based products, has released its condensed interim consolidated financial results for the period ended Dec. 31, 2023. According to the report, the company experience consistent growth and operational efficiency throughout Q3, with reported revenue of C$9,184,678 and a net loss of C$5,699,913. The report also noted that the company’s focus on profitability resulted in a 5% increase in gross profit margin compared to the same period in 2022. “Operating expenses notably decreased by C$1,829,856 compared to the same period in 2022, driven by prudent cost-cutting measures and heightened operational effectiveness,” stated the company in the press release. “Advertising, promotion, consulting and administrative expenses were all streamlined, reflecting the company’s commitment to fostering a sustainable and thriving business. The opening of the XMarket Vegan Food Hall and the strong financial performance in Q3 2024 signal PlantX’s dedication to elevating the plant-based lifestyle through culinary innovation and operational excellence.”

To view the full press release, visit https://ibn.fm/IbOas

About PlantX Life Inc.

PlantX is committed to being the digital face of the plant-based community as well as the one-stop shop for plant-based products. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. In addition to offering delivery service for meals and indoor plants, the company currently has plans underway to expand its product lines to include a juice and coffee company. PlantX uses its digital platform to build a community of like-minded consumers and, most importantly, to provide education. PlantX’s digital presence eliminates entry barriers for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information about this company, please visit www.PlantX.com and www.PlantX.ca.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is reporting its financial and operations results for the fourth quarter and full year 2023. A highlight of the report was net income for the year totaling $54.7 million, or $1.15 per share, versus the same period last year, which was a net loss of $81.1 million, or $1.71 per share. The report also noted that gold production at the Fox Complex and Gold Bar Mine came in just above the low end of guidance with San José coming in just below guidance; the report also noted that cash costs and AISC per ounce remain 12%–18% higher than guided. The company reported that its biggest single asset with the greatest near-term potential to increase share value is McEwen Copper, MUX’s 48%-owned subsidiary. The subsidiary’s second- and third-largest shareholders are mining company Rio Tinto and automaker Stellantis, which own 14.5% and 19.4% of McEwen Copper, respectively. McEwen Mining noted that McEwen Copper has 22 drills operating on site in order to complete the necessary work to deliver a bankable Feasibility Study in Q1 2025.

“Compared to conventional copper mines, Los Azules is designed with a much lighter impact on the environment, initially emitting one-third of the CO2-e emissions and progressing to net-zero carbon by 2038, utilizing one quarter the water, powered by 100% renewable electricity, and producing sustainable copper cathode,” said McEwen Mining chair and chief owner Rob McEwen in the press release. “At our Canadian and Mexican mines, we are advancing two important development projects. At the Fox Complex, the construction of the underground ramp access to the Stock orebodies will start in Q1. The Stock West deposit will become the primary source of production following the completion of mining at the Froome deposit in 2026. At the Fenix project, construction is expected to start in H2. Both of these projects are designed to extend the mine lives by over nine years.”

To view the full press release, visit https://ibn.fm/If1eA

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, the company owns approximately 47.7% of McEwen Copper, which is developing the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. Rob McEwen, chair and chief owner, has a personal investment in the group of $220 million and takes an annual salary of $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

DealFlow Events has re-engaged IBN, a multifaceted communications organization committed to connecting companies with the investment community through its dynamic portfolio of 60+ brands, as the official media partner for the 2nd Annual Venture Debt Conference 2024. Organized and hosted by DealFlow Events, the conference is slated to take place on March 6, 2024, at the historic Edison Ballroom in New York City. One of 200+ signature programs created by DealFlow, the Venture Debt Conference is designed to offer financially relevant, high-quality educational content, professional networking, and unique business development opportunities. As the event’s media sponsor, IBN will harness its comprehensive corporate communications solutions to enhance the conference’s visibility through a vast array of strategic tools and influential digital channels. “At DealFlow, we are pleased to once again collaborate with IBN for our March 2024 event,” said Charlie Napolitano, managing director of DealFlow Events. “As the market leader in corporate communications, IBN has consistently improved the outreach of our events while providing best-in-class media coverage. We are excited to continue our collaboration with IBN in March and appreciate their ongoing support.”

To view the full press release, visit https://ibn.fm/yiUdo

About DealFlow Events

DealFlow Events is widely recognized as a symbol of quality. For over two decades, DealFlow has created events that feature exclusive networking, education and business development opportunities. DealFlow Events has produced over 200 conferences, seminars and webcasts on a variety of financial topics. These events are the signature programs in their respective markets, offering high-quality content and professional networking opportunities. For more information, visit www.DealFlowEvents.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

GolfLync, a pioneering social networking platform for golf lovers, is celebrating a significant milestone: the company announced that it has reached — and passed — 100,000 members across the United States. According to the company, this achievement represents the platform’s ability to enhance the golfing experience and foster a robust, interconnected community of golf enthusiasts. Key to the success of the new platform is its innovative Virtual Golf Clubs(TM) (“VGCs”); currently there are more than 850 active clubs around the country. The clubs enable golfers to share experiences, organize tee times, host events and forge lasting connections. The company noted that its growth and success parallels strategies that other influential social media giants have utilized as they shaped the future of social networking and cultivated user engagement. Those companies include Facebook and Instagram (NASDAQ: META), Pinterest (NYSE: PINS), Match (NASDAQ: MTCH), LinkedIn Corp. (NYSE: LNKD) and Snap Inc. (Snapchat) (NYSE: SNAP). GolfLync is committed to redefine the sport of gold, providing a way for golfers to connect and engage with each other. “Surpassing 100,000 members is a milestone that fills us with immense pride,” said GolfLync cofounder and CEO Noah DiPasquale in the press release. “It echoes the strong sense of community our platform has nurtured, where golfers of all skill levels come together to share their passion. Our VGCs are more than just groups; they are thriving communities where friendships flourish.”

To view the full press release, visit https://ibn.fm/Ki12K

About GolfLync Inc.

GolfLync is a leading social networking platform designed exclusively for golfers. With a focus on community building and user engagement, GolfLync connects golf enthusiasts, fosters vibrant Virtual Golf Clubs(TM), and enhances the overall golfing experience. GolfLync is available for download on the Apple App Store and the Google Play Store. For more information about GolfLync, visit www.GolfLync.com.

NOTE TO INVESTORS: The latest news and updates relating to GolfLync are available in the company’s newsroom at https://ibn.fm/GOLF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, has scheduled a conference call and webcast. The company announced that during the call, company leaders will discuss the release of its fourth-quarter and year-end 2023 financial results as well as project development; the call will include time for questions from those in attendance. Those wanting to access the call can dial 888-210-3454 (toll free in North America) or 646-960-0130 (not toll free, international), and then use conference ID number 3232920. A replay of the webcast will be available following the call and will be available on the company’s website.

To view the webcast, visit https://ibn.fm/uNvcC

To view the full press release, visit https://ibn.fm/WhU9Z

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, the company owns approximately 47.7% of McEwen Copper, which is developing the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. Rob McEwen, chair and chief owner, has a personal investment in the company of $220 million. His annual salary is $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Women executives, professionals, influencers, solution providers, government organizations, investors, and those interested or involved in the pharma, biotech, medical device, and other healthcare systems, are invited to attend the 12th Advancing Women’s Leadership Skills & Opportunities in Pharma & Healthcare conference being held at the Hotel Tampa Riverwalk from March 25-27, 2024, in Tampa, FL.

As women expand their leadership roles to move up in their career paths, this summit offers them an important platform to seek and impart knowledge. They can connect with industry peers and leaders for meaningful connections. Top women pharmaceutical and biotechnology professionals will share their…

Read More>>

To know more, please visit (https://nnw.fm/BjcPn)

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, will be featured at the upcoming Sixth International Congress on Controversies in Fibromyalgia. The event is scheduled for March 7, 2024, in Brussels, Belgium. During the one-day event, Tonix Pharmaceuticals CEO Seth Lederman, MD, is slated to present. During his presentation, Lederman will provide an overview of data from the recently reported positive phase 3 RESILIENT trial of Tonmya(TM) (also known as TNX-102 SL) for the management of fibromyalgia.

To view the full press release, visit https://ibn.fm/1JAYl

About Tonix Pharmaceuticals Holding Corp.

Tonix is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s development portfolio is focused on central nervous system (“CNS”) disorders. Tonix’s priority is to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration in the second half of 2024 for Tonmya, a product candidate for which two positive phase 3 studies have been completed for the management of fibromyalgia. TNX-102 SL is also being developed to treat acute stress reaction as well as fibromyalgia-type Long COVID. Tonix’s CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication with Breakthrough Therapy designation. Tonix’s immunology development portfolio consists of biologics to address organ-transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (“CD40L” or “CD154”) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease. Tonix Medicines, the company’s commercial subsidiary, markets Zembrace(R) SymTouch(R) (sumatriptan injection) 3 mg and Tosymra(R) (sumatriptan nasal spray) 10 mg for the treatment of acute migraine with or without aura in adults. For more information about the company, please visit www.TonixPharma.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

IGC Pharma (NYSE American: IGC), a clinical-stage pharmaceutical company, reported on the results of preclinical studies evaluating its drug candidate TGR-63 as a treatment for Alzheimer’s disease. According to the report, the data showed enhanced memory function, including memory acquisition, consolidation and retrieval, in an Alzheimer’s mouse model. The preclinical studies included the use of two behavioral tests: the Novel Object Recognition (“NOR”) Test and the Morris Water Maze (“MWM”); APP/PS1 genetically modified Alzheimer’s mice were used in the evaluations. The company noted that its TGR-63 is a therapeutic candidate designed to disrupt the structure of the amyloid-β (Aβ) peptide in an attempt to reduce signs of cognitive impairment, such such as memory loss and disrupted learning ability. “These results underscore the efficacy of TGR-63 in enhancing spatial memory function in an Alzheimer’s disease model, offering promising implications for potential therapeutic interventions in Alzheimer’s and related neurodegenerative conditions,” said IGC Pharma CEO Ram Mukunda in the press release. “The improvements in memory acquisition, consolidation, spatial memory formation, and retrieval highlight its potential in addressing cognitive impairment in Alzheimer’s disease. We are optimistic about TGR-63’s potential and anticipate advancing it towards a phase 1 trial, enriching our clinical portfolio.”

To view the full press release, visit https://ibn.fm/wwPMN

About IGC Pharma

IGC Pharma is pursuing innovative solutions to fight Alzheimer’s disease and related challenges. The company’s portfolio comprises five assets, all with a singular mission: to transform the landscape of Alzheimer’s treatment. IGC-AD1 and LMP target neuroinflammation, Aβ plaques and neurofibrillary tangles. IGC-AD1 is currently in a phase 2b clinical trial for agitation in dementia due to Alzheimer’s. TGR-63 targets Aβ plaque to disrupt the progression of Alzheimer’s disease. IGC-M3 targets the inhibition of Aβ plaque aggregation with the potential to create a profound impact on early-stage Alzheimer’s. IGC-1C targets tau and neurofibrillary tangles as a forward-thinking approach to Alzheimer’s therapy. In parallel, IGC Pharma is at the forefront of generative AI development, with projects including clinical trials, early detection of Alzheimer’s and drug interactions with cannabinoids. For more information, visit the company’s website at www.IGCInc.us.

NOTE TO INVESTORS: The latest news and updates relating to IGC are available in the company’s newsroom at https://ibn.fm/IGC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), a leading innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, has deployed its K1 Hemisphere Autonomous Security Robots (“ASRs”) to two new clients: a church in Missouri and a hospital in Minnesota. The full-featured, compact devices are providing enhanced perimeter protection at these client properties, elevating safety for staff and visitors alike, reported Knightscope.

According to the announcement, KSCP’s K1 Hemisphere is an efficient, affordable entry point into leveraging Knightscope’s protective technologies. The platform, which can be mounted on many different surfaces, features three cameras that offer 210 degrees of eye-level, high-definition video; the solution also includes a strobe light, automatic license plate recognition, optional facial recognition, automated broadcast announcements, and an intercom that can run on either a wired or fully encrypted wireless network.

“Knightscope’s experience using artificial intelligence (‘AI) and machine learning to advance the future of physical security has grown significantly in accuracy and reliability since its first ASR deployment in May 2015,” said the company in the press release. “AI and analytics have helped clients accelerate the obsolescence of monitoring live video feeds by delivering real-time alerts when an anomaly is detected. As an example, ASRs can accurately detect people in places they should not be or at times of day they should not be there, identify known threats, read vehicle license plates and pinpoint the location of such detections, enabling faster forensic searches and response times to any threats.”

To view the full press release, visit https://ibn.fm/XzcbS

About Knightscope, Inc.

Knightscope builds cutting-edge technologies to improve public safety. The company’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Safety Shot (NASDAQ: SHOT), a pioneer in innovative well-being solutions, has appointed a new CEO. According to the company, Jarrett Boon, one of the original thought leaders and investors in LifeLock, will be taking over for Brian John, who is leaving to work with Elite Health Partners Inc., where he will focus on legacy Jupiter Wellness products. Boon was the cofounder and CEO of GBB Drink Lab, which developed Safety Shot, the company’s flagship product offering. As CEO, Boon will lead the launch and growth of the Safety Shot business. With more than three decades of experience in building, growing and selling businesses, Boon has gained invaluable expertise in in sales, marketing and strategic business development. “I thank Brian for the passion and commitment he has brought to Safety Shot and wish him well as he moves on to his next chapter with Elite Health Partners,” said Safety Shot CEO Jarrett Boon in the press release. “I am excited to take the business forward and even more excited about the tremendous potential that Safety Shot has to improve the health and well-being of millions of consumers in the growing $1.56 billion market. This is an amazing opportunity, and I will be dedicated to accelerating the growth of Safety Shot into a leading wellness beverage while increasing shareholder value.”

To view the full press release, visit https://ibn.fm/1ho8L

About Safety Shot

Safety Shot Inc., founded in 2018, is the first patented beverage that makes you feel better fast by reducing blood alcohol content and increasing mental clarity. Valued at $1.56 billion in 2020 and projected to grow at a CAGR of 14.6% through 2028, Safety Shot leverages scientifically proven ingredients to enhance metabolic pathways responsible for breaking down blood alcohol levels. The drink is purported to form a protective layer around the stomach, preventing residual alcohol absorption into the body. The formulation includes a tailored selection of all-natural vitamins, minerals, and nootropics, promoting faster alcohol breakdown and aiding in recovery and rehydration Safety Shot has been available for retail purchase since the first week of December 2023 at www.DrinkSafetyShot.com and www.Amazon.com . Additionally, the company plans to introduce business-to-business sales to distributors, retailers, restaurants, and bars in 2024. For more information about the company, visit www.SafetyShotHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to SHOT are available in the company’s newsroom at https://ibn.fm/SHOT

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Advanced Gold Exploration (CSE: AUEX), has appointed Dr. Andrew Ramcharan, PhD, P.Eng., as president of the company; the appointment was effective beginning Feb. 15, 2024. The company noted that current president Jim Atkinson is resigning as president, although he remains as CEO and as a company director. Ramcharan brings a deep background in investor relations and corporate strategies to his new position, having completed more than 300 project evaluations globally on many commodities and proposed 40-plus investment strategies; he has also been involved in the completion of two major takeover transactions worth $800 million and $1.5 billion and has raised more than $1 billion in funding. The company announced that is has granted Ramcharan stock options to purchase an aggregate of 150,000 common shares in the capital of the company in connection to his new appointment. In addition, the announcement also noted that Advanced Gold Exploration has appointed MS Partners LLP is its new auditor; the appointment has been reviewed by the board of directors and filed on SEDAR+. “I am pleased to announce the appointment of Dr. Andrew Ramcharan as president of the company,” said Advanced Gold Exploration CEO Jim Atkinson in the press release.

“Dr. Ramcharan has over 20 years’ unique experience in the mining industry, which includes investor relations, project evaluation, operations, capital markets, consultancy and investment banking. Andrew’s vast experience and sound technical knowledge coupled with a financial side will be valuable. . . . He will assist the company in the identification, analyzing and due diligence in evaluating mining projects or companies for mergers and acquisitions and investments, and will assist in technical areas within the company. We anticipate that his extensive contacts and knowledge in the business will be invaluable to the continued success of our company.”

To view the full press release, visit https://ibn.fm/493eg

About Advanced Gold Exploration Inc.

Advanced Gold Exploration (Formerly Advance United Holdings Inc.) brings an entirely different approach to the mining industry. The company doesn’t mine; rather, it has acquired a portfolio of undervalued gold properties and is increasing its value through the application of modern technology. Advanced Gold Exploration has a growing pipeline of similar properties that it is looking to acquire and is exclusively involved in the acquisition and advancement of past projects, with no intent to bring them back into production or to mine them ourselves. The company’s expertise is in identifying and acquiring undervalued properties with significant historical work, which were uneconomic at the time, but that have economic value at today’s prices. The company funds the reworking historic data and applies modern technology to underwrite new qualified reports, document quantifiable resources and reserves to current standards, thereby recognizing the current value. The company’s purpose is to bring immediate and long-term value to its partners and shareholders while seeking to eliminate exploration risk, so that its projects can all advance in the shortest possible time frame. To learn more about the company, visit www.AdvancedGoldExploration.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, will be participating in the 44th annual Cowen Healthcare Conference. The three-day event is slated for March 4–6, 2024, in Boston. During the conference, DarioHealth CEO Erez Raphael and president Rick Anderson will be featured in a fireside chat scheduled to begin at 10:30 a.m. on March 6. A replay of the chat will be available following the event. The company is focused on changing how people with chronic conditions manage their health by providing a user-centric, multichronic condition digital therapeutics platform and suite of solutions that deliver personalized interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health.

To view the fireside chat, visit https://ibn.fm/1jvKY

To view the full press release, visit https://ibn.fm/8kpkb

About DarioHealth Corp.

DarioHealth Corp. is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition digital therapeutics platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results, and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payors, self-insured employers and providers of care as well as directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Vistagen (NASDAQ: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced that company management will present and host one-on-one meetings at the TD Cowen 44th Annual Health Care Conference. The event is taking place from March 4 to 6, 2024, in Boston, Massachusetts. Vistagen CEO Shawn Singh will present a corporate overview on Wednesday, March 6, at 10:30 a.m. Eastern Time. A webcast will be accessible via the company’s website, through the “Events” page in the “Investors” section. Investors interested in scheduling a one-on-one meeting during the conference should contact their Cowen representative.

To view the full press release, visit https://ibn.fm/XuiNe

About Vistagen Therapeutics Inc.

Vistagen is a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders. Five of Vistagen’s clinical-stage neuroscience pipeline candidates belong to a new class of drugs known as pherines, which are investigational neuroactive nasal sprays with innovative proposed mechanisms of action that activate chemosensory neurons in the nasal passages to impact fundamental neural circuitry in the brain without the need for systemic absorption or binding to receptors in the brain. Vistagen’s sixth investigational candidate is an oral prodrug with potential to inhibit, but not block, NMDA receptor activity. Vistagen is passionate about delivering differentiated treatments that set new standards of care for people living with anxiety, depression and other neurological disorders. For more information, visit the company’s website at www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://nnw.fm/VTGN

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Silo Pharma (NASDAQ: SILO) is a developmental stage biopharmaceutical company focused on novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments. The company today announced positive results from its non-GLP small animal dose-ranging study of SPC-15, an intranasal prophylactic treatment for anxiety and post-traumatic stress disorder (“PTSD”). The purpose of the study was to identify the maximum tolerated intranasal dose of the drug pharmacokinetic and the therapeutically relevant dose range to be studied in clinical trials. Data analysis demonstrated rapid absorption of SPC-15 with good exposure over a 24-hour period, suggesting optimality of a once-per-day human intranasal dosing regimen. “Non-GLP and GLP toxicology and safety pharmacology studies are required steps before seeking approval for our first-in-human clinical-stage trials of SPC-15,” said Eric Weisblum, CEO of Silo. “We are currently on track to submit a pre-investigational New Drug Application (‘IND’) to the FDA by the end of the second quarter 2024. This is an exciting step forward for our company as we advance our lead therapeutic, SPC-15.”

To view the full press release, visit https://ibn.fm/2x7R7

About Silo Pharma Inc.

Silo Pharma is a developmental-stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions and central nervous system (“CNS”) diseases. Silo focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. SP-26 is a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. Silo’s two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (“MS”). Silo’s research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is reporting on three results of its large exploration investment at the Stock Mine property, which is part of the Fox Complex located in the prolific Timmins gold district of Northern Ontario. According to the announcement, the three outcomes include the following: a 31% year-over-year increase of gold resources at Stock West and Stock Main (historic Stock Mine); a confirmation of good grading structures plunging to depth; and Stock East emerging as a potential new near-term source of future revenue. “Exploration drill core samples at the Stock Complex were typically submitted as 1/2 core,” said the company in the press release. “Analyses reported herein were either performed by the fire assay method at the accredited laboratory Pangea Laboratorio in Sinaloa, Mexico, owned and operated by an indirect subsidiary of the company, or by the photon assay method at the accredited laboratory MSA Labs in Timmins, Ontario, Canada.”

To view the full press release, visit https://ibn.fm/QHrWi

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, the company owns approximately 47.7% of McEwen Copper, which is developing the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. Rob McEwen, chair and chief owner, has a personal investment in the company of $220 million. His annual salary is $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

The Alternative Products Expo is coming to Miami March 14-16, 2024. A leading organizer of CBD & Hemp products, the Alternative Products Expo offers niche manufacturers and service providers a common forum to network and showcase their products.

The Alternative Product category includes a broad spectrum of herbal products, mood enhancers, vape products, energy boosts, cannabis derivatives, and dietary supplements, to name a few. As Florida is a major hub of alternate lifestyles and trendsetting products, Miami emerges as a suitable venue for the…

Read More>>

To know more, please visit https://altproexpo.com/

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

• Early-stage lending fell 44% year-over-year in the first six months of 2023 following Silicon Valley Bank collapse
• Demand for venture debt remains strong for companies that aim to preserve control, stay autonomous, and maintain flexibility over capital structure
• Hosted by DealFlow Events, The Venture Debt Conference on March 6, 2024, in New York City features 30+ experts, interactive panel discussions, and opportunities to meet with the largest group of dealmakers in the lending business
• Emerging venture debt lenders bring expertise to startups and new companies navigating complex financial arrangements
• Attendance is free for qualified C-level executives representing a venture-backed or emerging growth company

The collapse of Silicon Valley Bank (SVB last year had a  significant impact on the venture debt market, resulting in a 44% year-over-year drop in early-stage lending during the first six months of 2023. Despite SVB’s failure, demand for venture debt remained strong. What was initially a major debt hole has since been filled by lending firms offering high-level insights and technological expertise.

Venture debt is favored by many startups and high-growth companies – especially those that want to preserve control and maintain autonomy without giving up equity. Venture debt can also provide startups with predictable repayment schedules and interest rates, enabling them to optimize…

Read More>>

Learn more about the Venture Debt Conference and review the full program agenda.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, has completed the clinical stage of its phase 1 single ascending dose escalation trial, designed to evaluate TNX-1500 (Fc-modified humanized anti-CD40L monoclonal antibody, or mAb) in healthy volunteers. According to the announcement, the company anticipates receiving topline results from the trial in Q3 2024 and is now planning a phase 2 trial focused on evaluating the drug for prevention of kidney transplant rejection.

In addition, Tonix Pharmaceuticals CEO Seth Lederman, MD, was featured in two releases from Proactive, a best-in-class media provider of 24/7 breaking news, commentary and analysis on hundreds of listed and pre-IPO companies around the globe. In the videos Lederman and Proactive host Steve Darling discuss two key news releases from Tonix: positive results from a phase 3 study on Tonmya, also known as TNX-102 SL, for the management of fibromyalgia, and the clearance of the Investigational New Drug application by the U.S. Food and Drug Administration for the company’s phase 2 investigator-initiated OASIS trial.

To view the videos, visit https://ibn.fm/yiFou and https://ibn.fm/66mmh.

To view the full press releases, visit https://ibn.fm/tjE3X, https://ibn.fm/XFUBN and https://ibn.fm/HktND.

About Tonix Pharmaceuticals Holding Corp.

Tonix is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s development portfolio is focused on central nervous system (“CNS”) disorders. Tonix’s priority is to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration in the second half of 2024 for Tonmya, a product candidate for which two positive phase 3 studies have been completed for the management of fibromyalgia. TNX-102 SL is also being developed to treat acute stress reaction as well as fibromyalgia-type Long COVID. Tonix’s CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication with Breakthrough Therapy designation. Tonix’s immunology development portfolio consists of biologics to address organ-transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (“CD40L” or “CD154”) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease. Tonix Medicines, the company’s commercial subsidiary, markets Zembrace(R) SymTouch(R) (sumatriptan injection) 3 mg and Tosymra(R) (sumatriptan nasal spray) 10 mg for the treatment of acute migraine with or without aura in adults. For more information about the company, please visit www.TonixPharma.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

DealFlow Events, host of hundreds of conferences over the past two decades, has selected IBN as the official media partner for the upcoming Activist Investor Conference 2024. DealFlow Events is organizing and hosting the event, which is slated for March 21, 2024, in New York City. Focused on the industry’s most innovative and transformative ideas, the conference has been around for more than a decade and is designed to provide invaluable opportunities for professional education and networking as well as forging new business relationships. Information presented during the event is designed to support investors as they work on deepening their knowledge of governance issues and improving the fortunes of the companies in which they have invested. Conference attendees come from a wide array of sectors, including activist investors, rating platforms, hedge funds and public equity investors, corporate governance specialists, advisory firms, proxy solicitors and corporate board members. IBN is a multifaceted communications organization committed to connecting companies with the investment community through its dynamic portfolio of 60-plus brands.

As media sponsor, IBN will leverage its complete corporate communications platform to increase awareness of the conference and expand the visibility of invited speakers and presenters as well as event sponsors. “At DealFlow, we are excited to renew our collaboration with IBN for the Activist Investor Conference 2024 event,” said DealFlow Events managing director Charlie Napolitano in the press release. “IBN has consistently provided state-of-the-art communications services, optimized our outreach to relevant audiences, and offered highly-effective media coverage. We appreciate IBN’s ongoing support and look forward to a lasting partnership.”

To learn more about the conference, visit https://ibn.fm/SHrBn

To view the full press release, visit https://ibn.fm/pLYGn

About DealFlow Events

DealFlow Events is widely recognized as a symbol of quality. For more than two decades, DealFlow has created events that feature exclusive networking, education and business-development opportunities. In addition, DealFlow Events has produced more than 200 conferences, seminars and webcasts covering a variety of financial topics. These events are the signature programs in their respective markets, offering high-quality content and professional networking opportunities. To learn more about the company, please visit www.DealFlowEvents.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

RB Capital Partners, a judgment creditor against Optec International Inc. (OTC: OPTI), today announced its engagement of Mark Basile and The Basile Law Firm P.C. to work with the courts to officially appoint a receiver to run Optec in the interim while a new company is merged into the public vehicle. RB Capital, the largest investor and legitimate shareholder of Optec International, was forced to bring a shareholder derivative action against Optec to secure the company’s judgment, oust Roger Pawson and to try to preserve Optec’s assets. According to the announcement, the next step in the process is to officially appoint a receiver in order for the new management to obtain control of Optec/OPTI, the public vehicle, and ultimately access to OTC Markets via OTCIQ. “We are working very diligently with all parties involved to get this matter resolved as fast as possible so Optec can begin the next chapter of the company’s story,” said Brett Rosen, managing partner of RB Capital Partners. “In order to promote transparency, RB Capital commits to making consistent updates about Optec via press releases and social media posts. We could have easily just walked away with our judgement, but Deborah and I stayed and took on the responsibility of Optec so we can make this right for all those who were wronged by the former CEO’s actions.”

To view the full press release, visit https://ibn.fm/MrRSE

About RB Capital Partners Inc.

RB Capital Partners is a private investment fund headquartered and incorporated in California. The main investment focus of RB Capital is on small and microcap publicly traded companies trading on the OTC Markets, Nasdaq and New York Stock Exchange. RB Capital predominantly makes debt investments and is known for paying off any harmful convertible debt, giving companies a real chance at success. RB Capital Partners does NOT manage any outside money, nor does it have any investors. It is run and funded solely by Brett Rosen and Deborah Rosen who each have a 50% ownership stake in the company.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

CISO Global Inc. (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider (“MSSP”), has appointed a seasoned tech executive to its board of directors. The company announced that Brett Chugg has joined the board and provide strategic support and guidance as the company focuses on the next stage of growth underpinned by its software-first product platform strategy. Chugg brings a depth of experience to his board role, including his most recent service as senior managing director at Koch Disruptive Technologies, a venture and growth equity investment group at Koch Industries. Prior to joining Koch, Chugg served in a variety of positions, including as director on several high-growth company boards, such as Insightec, Vayyar, Valo Health, Shine Technologies and Cohere Communications. Chugg has a proven track record as an investor and leader in technology with global, multi-industry experience including hardware, software, manufacturing, healthcare and petrochemical markets.

“CISO Global is undergoing transformative growth,” said CISO Global CEO David Jemmett in the press release. “This is a pivotal time for Brett to join our company and further enable its continued evolution with his deep experience, strategic capabilities and highly sought after business acumen. He shares our vision of the critical role our talent and software-first solutions are playing in outpacing competitors with our leading managed security and compliance services.”

To view the full press release, visit https://ibn.fm/3DYqx

About CISO Global Inc.

CISO Global is based in Scottsdale, Arizona, and is a top 25 managed cybersecurity and compliance services provider that is delivering innovative solutions through its newly developed artificial intelligence (“AI”) and machine-learning (“ML”)-powered product portfolio. The company protects the most demanding businesses and government organizations against continuing and emerging security threats and ensures their compliance obligations are being met. For more information about the company, visit www.CISO.inc.

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Safety Shot (NASDAQ: SHOT) today announced its appointment of Danielle De Rosa as its new chief financial officer effective March 1, 2024. A multifaceted, analytical and results-driven professional, Rosa brings more than 25 years of experience in all aspects of financial services and operational functions including serving as a public company CFO. “With the national launch of our highly anticipated functional beverage, Safety Shot, our revenue and operations structure are changing rapidly. We’re bringing Danielle on board to benefit from her strategic and diligent approach to managing growth, cash flow, inventory, and operations,” said Safety Shot CEO Brian John. “She’s successfully managed growing teams and assets at public and private companies. We’re pleased to welcome her aboard.”

To view the full press release, visit https://ibn.fm/1cN0q

About Safety Shot Inc.

Safety Shot, a wellness and functional beverage company, is set to launch Safety Shot, the first patented wellness beverage on Earth that helps people feel better faster by reducing blood alcohol content, boosting clarity and overall mood. Safety Shot is available for retail purchase at www.DrinkSafetyShot.com and www.Amazon.com. The company plans to launch business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars in the first quarter of 2024. Safety Shot recently announced plans to spin off legacy assets from its Jupiter Wellness business to unlock value for shareholders.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Hillcrest (CSE: HEAT) (OTCQB: HLRTF) (FSE: 7HI), an innovative clean technology company redefining power conversion technologies, today announced the addition of Dan Mathieson as a strategic advisor to the company. Mathieson will work with Hillcrest’s executive team to deliver new business expansion opportunities both domestically and internationally. “Dan is a genuine innovator driven by a commitment to propel Canada forward,” said Hillcrest’s Chief Executive Officer Don Currie. “Over the past two decades, he’s successfully demonstrated his ability to drive progress and push boundaries to propel his community forward. During that time, he also cultivated a valuable network of like-minded leaders globally and will play a pivotal role in ensuring Hillcrest’s successful advancement. On behalf of the board and the entire Hillcrest team, we extend a warm welcome to Dan and eagerly anticipate our collaboration.”

To view the full press release, visit https://ibn.fm/cUqDQ

About Hillcrest Energy Technologies Ltd.

Hillcrest is a clean technology company focused on providing advanced power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable energy systems. From concept to commercialization, Hillcrest is investing in the development of energy solutions that will power a more sustainable and electrified future. Hillcrest is publicly traded on the CSE under the symbol HEAT, on the OTCQB Venture Market as HLRTF and on the Frankfurt Exchange as 7HI. For more information, please visit www.HillcrestEnergy.tech.

NOTE TO INVESTORS: The latest news and updates relating to HLRTF are available in the company’s newsroom at https://ibn.fm/HLRTF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Cybin (NYSE American: CYBN) (Cboe CA: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, will be spotlighted at next month’s 44th annual TD Cowen Health Care Conference. The three-day event is scheduled for March 4–6, 2024, in Boston. During the conference, Cybin CEO Doug Drysdale will be presenting. His presentation is slated to begin at 12:50 p.m. ET on March 4. Drysdale’s presentation will be available live on a webcast; a replay of his presentation will also be available following the live event on the company’s investor relations website. 

To view the presentation, visit https://ibn.fm/FCAus

To view the full press release, visit https://ibn.fm/pKif0

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental-health conditions. Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug-discovery platforms, innovative drug-delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder; the company also has a research pipeline of investigational psychedelic-based compounds. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, is reporting positive results from its clinical pharmacokinetic (“PK”) bridging study of Tonmya(TM). The study evaluated the efficacy of Tonmya, also known as TNX-102 SL (cyclobenzaprine HCl sublingual tablets), in healthy adult male and female ethnic Japanese and Chinese volunteers. The report noted that Tonmya was generally well tolerated in the ethnic Japanese and Chinese healthy volunteers. Tonix holds issued patents for market exclusivity rights of Tonmya in Japan, China, Hong Kong and Taiwan.”

“This bridging study is an important first step as we begin evaluating the potential for approval and marketing Tonmya in Japan and China,” said Tonix Pharmaceuticals CEO Seth Lederman, MD, in the press release. “The results show a similar pharmacokinetic profile in ethnic Japanese and Chinese volunteers with a Caucasian comparator group. As a result, we believe that these data, with supporting results recently reported from the positive phase 3 RESILIENT study, are the only clinical data needed to support regulatory filings in Japan and China.”

To view the full press release, visit https://ibn.fm/FmAfl

About Tonix Pharmaceuticals Holding Corp.

Tonix is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s development portfolio is focused on central nervous system (“CNS”) disorders. Tonix’s priority is to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration in the second half of 2024 for Tonmya, a product candidate for which two positive phase 3 studies have been completed for the management of fibromyalgia. TNX-102 SL is also being developed to treat acute stress reaction as well as fibromyalgia-type Long COVID. Tonix’s CNS portfolio includes TNX-1300 (cocaine esterase) a biologic designed to treat cocaine intoxication with Breakthrough Therapy designation. Tonix’s immunology development portfolio consists of biologics to address organ-transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (“CD40L” or “CD154”) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease. Tonix Medicines, the company’s commercial subsidiary, markets Zembrace(R) SymTouch(R) (sumatriptan injection) 3 mg and Tosymra(R) (sumatriptan nasal spray) 10 mg for the treatment of acute migraine with or without aura in adults. For more information about the company, please visit www.TonixPharma.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Vocodia Holdings Corp. (CBOE: VHAI, VHAI+A, VHAI+B), a software company that builds practical AI functions, recently announced the pricing of its underwritten initial public offering of 1,400,000 units, each consisting of one share of common stock of the company, par value $0.0001 (“Common Stock”), one Series A Warrant to purchase one share of Common Stock at $4.25 (the “Series A Warrant”), and one Series B Warrant to purchase one share of Common Stock at $8.50 (the “Series B Warrant”), at a price to the public of $4.25 per unit. Gross proceeds from the offering were expected to be approximately $5,950,000. In addition, Vocodia granted the underwriters a 45-day option to purchase up to 210,000 additional units at the public offering price, less the underwriting discount. The company intends to use the net proceeds for the acquisition of websites, technologies or other assets, building an improved switch, and for expanding its product offering from other digital channels, sales and marketing, working capital and other general corporate purposes. Alexander Capital, L.P. acted as sole book-running manager for the offering. Sichenzia Ross Ference Carmel LLP served as counsel to the company, and Sullivan & Worcester LLP served as counsel to the underwriters.

To view the full press release, visit https://ibn.fm/5XSBT

About Vocodia Holdings Corp.

Vocodia is an AI software company that builds practical AI functions and makes them easily obtainable for businesses on cloud-based platform solutions at low costs and scalable to multiagent vast enterprise solutions. Vocodia is a conversational AI software developer and provider that offers scalable enterprise-level AI sales and customer service solutions that allow for AI sales representatives to reduce human labor costs and responsibilities while increasing the reach and efficacy of human-led, purposeful, agenda driven and conversational communications. Vocodia deliver its patent pending conversational AI software in the form of Digital Intelligent Sales Agents (the “DISAs”), which are built with AI software programmed to sound and feel human and to perform business tasks that require humans to converse with one another effectively, and thus to provide the best representation for each of its customers’ businesses. For more information, please visit: www.Vocodia.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, and McEwen Copper Inc. have released assay results from the final unreleased drill holes of the 2022–2023 season. According to the report, the results validate previous drilling results and confirm the continuity of mineralization as well as extend the mineralization. Highlights from the report indicate the following: hole AZ23 205 MET returned 257 m of 0.76% Cu within the Enriched zone; hole AZ23 228 MET returned 446 m of 0.63% Cu in the Enriched zone, including 76 m of 0.92% Cu; and hole AZ23 230 MET returned 250 m of 0.68% Cu in the Enriched zone, including 192 m of 0.83% Cu. The company noted that the goal of the drilling campaign was to collect information needed as the project advances toward the completion of a feasibility study. Work will continue during the 2023–2024 field season toward this objective; that work will include resource, geotechnical, metallurgical, hydrogeological, exploration and condemnation drilling.

The report noted that the Los Azules project is fully funded with investments from both Nuton, a Rio Tinto venture, and Stellantis; McEwen Copper is seeking funding to support feasibility-level engineering and preconstruction work. “McEwen Copper’s Los Azules project is progressing at light speed towards completing a feasibility study by Q1 2025, and it has already delivered significant economic benefits to the neighboring communities,” said McEwen Copper vice president and general manager Michael Meding in the press release. “It is a very large copper resource, where recent exploration drilling suggests it definitely has room to grow.”

To view the full press release, visit https://ibn.fm/XF1YO

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, the company holds a 47.7% of McEwen Copper, which is developing the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. Rob McEwen, chair and chief owner, has a personal investment in the company of $220 million. His annual salary is $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Infobird (NASDAQ: IFBD), a software-as-a-service(“SaaS”) provider of innovative, AI-powered or artificial intelligence-enabled customer engagement solutions, today announced that it is amending the effective date for its reverse stock split. Due to an unanticipated delay in obtaining necessary regulatory clearances, the effective date was revised to Monday, March 4, 2024, where trading will begin at market open on a split-adjusted basis.

To view the full press release, visit https://ibn.fm/Mq6mL

About Infobird Co. Ltd.

Infobird is a software-as-a-service (“SaaS”) provider of innovative, AI-powered or artificial intelligence-enabled customer engagement solutions. For more information, visit Infobird’s website at www.Infobird.com.

NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), a leading innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, announced that its fifth-generation K5 autonomous security robot (“ASR”) is the newest member of the team at Margaritaville Resort Casino in Bossier City, Louisiana. According to the update, this marks the 5th and most recent deployment as part of a larger master agreement announced in September with the operator of integrated entertainment, sports content and casinos.

The announcement reads, “The Knightscope ASR is driven by proprietary AI software that enhances safety measures at the property while providing visitors with a unique, interactive guest experience with Margaritaville-branded graphics, a client-chosen voice for custom audio broadcast messaging, improved access to emergency services and plenty of opportunities for robot selfies.”

To view the full press release, visit https://ibn.fm/NTiTF

About Knightscope, Inc.

Knightscope builds cutting-edge technologies to improve public safety, and its long-term ambition is to make the United States of America the safest country in the world. For more information or to book a discovery call or demonstration, visit the company’s website at www.knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including health and wellness, nutraceuticals, food and beverage, cosmetics, biotherapeutics, and more, is releasing information on the growth of its recent acquisition: Uncle Bud’s Health & Wellness. According to the company, Amazon sales of the product have experienced a 60% increase over the previous month, with direct-to-consumer (“DTC”) sales Increasing by 16% from the previous month. In addition, the DTC customer base has increased by 13% and the company has seen “unprecedented” DTC subscription growth, with new subscriptions surging by 138% in the last month and website traffic increasing by 142%. The company noted that it anticipates the announcement of several high-profile celebrities as well as the launch of an extensive influencer campaign. The Uncle Bud’s line began in 2018 with a hemp-based pain relief product and has become a leader in the hemp seed oil, cannabidiol (“CBD”) and health & wellness sectors.

“We are thrilled to witness such dynamic growth in our DTC metrics, a testament to the trust and loyalty our customers have in Uncle Bud’s products, as well as anticipatory excitement for the promise of PBIO’s new nanoemulsion product enhancement capabilities,” said Uncle Bud marketing director Garrett Greller in the press release. “The significant upswing in new subscriptions, customers, revenue and website traffic are not just numbers to us; they represent real people exploring and definitively choosing better-for-you wellness and natural solutions for their everyday lives. Moreover, our forthcoming collaborations with high-profile celebrities and the launch of our influencer campaign will not only enhance brand visibility but will reinforce our deep-rooted engagement and adoption of cutting-edge science-driven improvements. They will also strengthen our mission to make Uncle Bud’s extraordinary wellness accessible to everyone. We are on an exciting path of growth and innovation, and these results are just the beginning of what promises to be a rewarding journey ahead for all PBIO stakeholders.”

To view the full press release, visit https://ibn.fm/YiuDt

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high-pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical and agrochemical, as well as food and beverage manufacturing. PBIO’s patented enabling platform, Pressure Cycling Technology (“PCT”), utilizes alternating cycles of pressure to control biomolecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counterbioterrorism applications. The company’s patented BaroFold(TM) technology platform allows PBIO to enter the biopharma contract services and GMP manufacturing equipment sector. PBIO has also developed the scalable and high-efficiency pressure-based UltraShear Technology(TM) platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room-temperature-stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. The company’s commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information, visit the company website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Flora (NASDAQ: FLGC), a cannabis focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, today issued an update to applaud the German parliament for voting in favor of legalizing cannabis for recreation use. After obtaining the first medical cannabis license in Germany, Flora’s wholly owned subsidiaries are responsible for selling the first gram of medical cannabis in the country and have been active there since 2017. “The decision marks a historic day for cannabis in Germany,” said Flora CEO Clifford Starke. “The legalization of recreational cannabis in Europe’s leading economy and the easing of access to medicinal cannabis will benefit consumers and patients tremendously. On behalf of Flora, we welcome Germany’s decision and look forward to playing an important role in the process.”

To view the full press release, visit https://ibn.fm/bHCgv

About Flora Growth Corp.

Flora is a cannabis-focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world. For more information on Flora, visit www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Save Foods (NASDAQ: SVFD) (FSE: 80W), a pioneer agri-food tech company offering sustainable solutions for agriculture and plant based food, today announced the commencement of commercial activity in Brazil. According to the announcement, the company’s entry into the Brazilian market was facilitated by its local exclusive distributor after confirming that Save Foods’ solutions comply with local regulations. “As the country is put under pressure to comply with the Farm to Fork Strategy aligned with the European Green Deal, it has become increasingly crucial for suppliers of fresh fruit and vegetables to proactively adopt sustainable practices and stay ahead of evolving standards,” said Antonio Lunguinho, the CEO of Oxytrade Comercio and Ricardo Picard, the CEO of Endeavor Biologics . “We are thrilled to represent Save Foods in Brazil and combine our strengths with Save Foods’ innovative solutions. We are glad Save Foods’ products are cleared for distribution and we are looking forward to start our commitment to buying minimum quantities. We believe this partnership is poised to revolutionize the post-harvest treatment of fresh produce starting with limes and mangos, benefiting farmers, distributors and consumers alike.”

To view the full press release, visit https://ibn.fm/ZyfD6

About Save Foods Inc.

Save Foods is an innovative agri-food tech company that through its three operational arms delivers integrated solutions for improved safety, quality and sustainability every step of the way from field to fork. Save Foods Ltd., Save Foods’ majority owned Israeli subsidiary, focuses on post-harvest treatments in fruit and vegetables to control and prevent pathogen contamination, significantly reduce the use of hazardous chemicals, and prolong fresh produce’s shelf life. Nitrousink Ltd., Save Foods’ majority owned Israeli subsidiary, contributes to tackling greenhouse gas emissions, offering a pioneering solution to mitigate N2O (nitrous oxide) emissions, a potent greenhouse gas with 265 times the global warming impact of carbon dioxide. Nitrousink aims to promote agricultural practices that are both environmentally friendly and economically viable. Plantify Foods Inc. (PTFY), Save Foods’ minority owned Canadian subsidiary listed on the TSXV, offers a wide range of clean-label healthy food options that are nutritious, gluten free, non-allergenic, use whole natural ingredients, and are easy to prepare. For more information, visit the company’s website at https://savefoods.co.

NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD         

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

• Activist investors target underperforming companies with an eye toward implementing agendas to maximize shareholder value
• Efforts by the SEC to limit activist interventions include proposals to shorten Schedule 13 filing deadlines, mandate amendments within a day of significant changes, and prevent shareholders from interfering with a company’s pro-ESG initiatives
• Activist investors tackle ongoing challenges by staying on top of emerging trends, adopting best practices, and forming strategic alliances
• DealFlow Events presents an unparalleled networking and learning opportunity: The Activist Investor Conference on March 21, 2024, in New York City
• Like all DealFlow events, this conference promises to deliver. The event features 20+ experts discussing topics covering value investing strategies, legal issues, corporate relations, and international opportunities

Activist investors remain a force to be reckoned with. They target companies perceived to be underperforming or inefficient and implement strategies to maximize shareholder value.

That’s why they’re also called…

Read more>>

As with all DealFlow Events, the Activist Investor Conference promises to deliver. Learn more and register.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN